课题基金 / 基金详情

6TH INTL CONF ON ALZHEIMER DISEASE AND RELATED DISORDERS

6TH INTL CONF ON ALZHEIMER DISEASE AND RELATED DISORDERS
第六届阿尔茨海默病及相关疾病国际会议
批准号:
2683186
负责人:
KHALID IQBAL
金额:
$4.61万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-07-15 至 1999-06-30

项目摘要

项目成果

KHALID IQBAL的其他基金

相关文献

中文摘要
翻译
阿尔茨海默病已成为#年主要研究领域之一 神经科学。……的速度有了极大的提高。 关于阿尔茨海默氏症和相关疾病的优秀出版物。 两年一度的阿尔茨海默病国际会议和 1988年开始的相关疾病吸引了350多名科学家 来自世界各地。首届阿尔茨海默病国际会议 S病于1988年7月在拉斯维加斯举行,第二届会议于 1990年7月,加拿大多伦多,大约750名科学家参加了会议, 1992年在意大利帕多瓦举行的第三次会议,有1000人参加 科学家,1994年在明尼阿波利斯举行的第四次会议 1220名科学家,1996年第五次会议在日本大阪举行 1600多名科学家参加了会议。自1996年上次会议以来, 关于病因学的重要信息仍在继续, 临床病程、鉴别诊断、流行病学和危险因素, 组织病理学课程,遗传学,分子遗传学,模型系统, 和治疗学,以及相关的神经变性。具体的 赠款申请的目的包括宣传第六次会议, 征集和评审摘要,鼓励有才华的美国青年 调查人员(研究生、博士后研究员和教职员工 成员晋升为助理教授)。荷兰阿姆斯特丹 已经几年被选为第六届会议的地点 理由。这将是一次国际性会议。第一个 第四次会议在美国举行(拉斯维加斯和 明尼阿波利斯),第二届会议在加拿大(多伦多),第三届 在意大利的帕多瓦,在日本的大阪。第六次 在这次会议上,欧洲的科学家们正在生产大量的HIGH 高质量的痴呆症研究,是时候增加他们的 与他们在美国的同事进行互动和协作 各州。此外,迪克·斯瓦布教授不仅受到他的尊重 国际学术科学同行,但由研究人员和 欧洲制药公司的高级经理,这将是 使当地组织者能够承保和补贴许多 会议费。应用程序请求资金来支付 美国初级调查人员的旅行;他们将根据 以竞争为基础。如果这项申请得到资助,它将成为一项重大的 为第六届联合国气候变化框架公约国际会议的成功作出贡献 阿尔茨海默病及相关疾病。
英文摘要
Alzheimer Disease has become one of the major areas of research in neuroscience. There has been a tremendous increase in the rate of excellent publications on Alzheimer's disease and related disorders. The Biennial International Conferences on Alzheimer's Disease and Related Disorders which started in 1988 attracting over 350 scientists from around the world. The First International Conference on Alzheimer s Disease was held in Las Vegas in July, 1988, the Second conference in Toronto, Canada in July, 1990, attended by approximately 750 scientists, the Third conference in Padova, Italy, 1992 attended by 1,000 scientists, the Fourth conference in Minneapolis in 1994 attended by 1,220 scientists, and the Fifth conference in 1996 is Osaka, Japan attended by over 1,600 scientists. Since the last Conference in 1996, important information continues to be made regarding the etiology, clinical course, differential diagnosis, epidemiology and risk factors, histopathological course, genetics, molecular genetics, model systems, and therapeutics, as well as related neurodegeneration. The specific aims of the grant application include publicizing The Sixth Conference, soliciting and reviewing abstracts, encouraging talented junior U.S. investigators (graduate student, post doctoral fellows and faculty members up the rank of assistant professor). Amsterdam, The Netherlands has been selected as a site for the Sixth Conference for several reasons. This is intended to be an international conference. The First and Fourth conferences were held in the United States (Las Vegas and Minneapolis), The Second Conference was in Canada (Toronto), the Third in Padova, Italy, and the Fifth in Osaka, Japan. For the Sixth Conference, scientists in Europe are producing a large volume of high quality dementia research and the time has come to increase their interaction and collaboration with their colleagues in the United States. Additionally, Professor Dick Swaab is not only respected by his international academic scientific colleagues, but by the researchers and senior managers of the European Pharmaceutical companies, which will enable the local organizers to underwrite and subsidize many of the conference expenses. The application requests funds to pay for the travel of junior U.S. investigators; they will be selected on a competitive basis. If this application is funded, it will make a major contribution to the success of the Sixth International Conference on Alzheimer's Disease and Related Disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Treatment of Alzheimer's disease by clearing both tau and amyloid beta pathologies
  • 批准号:
    10545157
  • 项目类别:
  • 资助金额:
    $50.0万
  • 财政年份:
    2022
  • 负责人:
    KHALID IQBAL
  • 依托单位:
Treatment of Alzheimer's disease by clearing both tau and amyloid beta pathologies
  • 批准号:
    10772916
  • 项目类别:
  • 资助金额:
    $5.37万
  • 财政年份:
    2022
  • 负责人:
    KHALID IQBAL
  • 依托单位:
I2PP2A: A Therapeutic Target
I2PP2A: A Therapeutic Target